Philadelphia Biotech Startup Context Therapeutics Names a New CFO, Effective Immediately Post author:Sam Post published:November 15, 2017 Post category:BioPharma The company is strengthening its team as it transitions to a clinical development stage company. Source: BioSpace You Might Also Like Money Problems Push SoCal's ImmunoCellular To Suspend Trial, Seek Strategic Alternatives June 20, 2017 MyoKardia Sees Positive Results in Mid-Stage Heart Trial March 8, 2018 On a Roll: FDA Calls Sage's Depression Drug a Breakthrough February 6, 2018
Money Problems Push SoCal's ImmunoCellular To Suspend Trial, Seek Strategic Alternatives June 20, 2017